# Entecavir for Biological Agents Associated HBV Reactivation in Inflammatory Arthritis Patients

> **NCT01907230** · PHASE4 · UNKNOWN · sponsor: **Taipei Veterans General Hospital, Taiwan** · enrollment: 115 (actual)

## Conditions studied

- Rheumatoid Arthritis
- Hepatitis B Reactivation
- Exposure to Hepatitis B Virus

## Interventions

- **DRUG:** Entecavir

## Key facts

- **NCT ID:** NCT01907230
- **Lead sponsor:** Taipei Veterans General Hospital, Taiwan
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-09-10
- **Primary completion:** 2018-12-31
- **Final completion:** 2019-12-31
- **Target enrollment:** 115 (ACTUAL)
- **Last updated:** 2019-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01907230

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01907230, "Entecavir for Biological Agents Associated HBV Reactivation in Inflammatory Arthritis Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01907230. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*